Drugs / Delayed Cold-Stored Buffy Coat Platelets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06147531 | Jun 2024 → Sep 2026 overdue | hemorrhagic disease, platelet disorder, undefined | University Health Network, Toronto | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Delayed Cold-Stored Buffy Coat Platelets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06147531 ↗ |
| Known as | DCSP | “Recent studies suggest converting RTP to cold-stored platelets (Delayed Cold-Stored Platelets, DCSP) may be an important way of extending platelet lifespan and increasing...” PMID 38879518 ↗ Jun 2024 |
| Route | Other | “platelet transfusions” NCT06147531 ↗ |